表紙:カイフォプラスティ(後弯形成術)の市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年
市場調査レポート
商品コード
1321354

カイフォプラスティ(後弯形成術)の市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年

Kyphoplasty Market Size, Share & Trends Analysis Report By Product (Balloon Catheters, Bone Access Devices), By Application, By Indication, By End-use (Hospitals & Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 - 2030


出版日
ページ情報
英文 150 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
カイフォプラスティ(後弯形成術)の市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント予測、2023年~2030年
出版日: 2023年07月07日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

カイフォプラスティ(後弯形成術)市場の成長と動向

Grand View Research社の最新レポートによると、世界のカイフォプラスティ市場規模は2030年までに9億5,080万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 5.3%で拡大する見込みです。高齢者人口の増加が、予測期間中の市場成長に寄与する主な要因です。圧迫骨折は世界中で多くの人々に影響を及ぼしています。椎体圧迫骨折(VCF)は骨粗鬆症患者における最も一般的な骨折であり、毎年約75万人が罹患しています。この疾患の発生は高齢になるにつれて徐々に増加し、80歳以上の女性の40%が罹患していると推定されています。

COVID-19の発生中、緊急でない手術がカイフォプラスティ市場に大きな影響を与えました。規制の結果、多くの手術に遅れが生じたからです。ほとんどの国では、選択的手術に対する規制が強化されています。2020年4月、北米脊椎学会(NASS)は、緊急手術、緊急手術、選択的手術という分類における手術や処置に関する臨床的考察と推奨を包括的にまとめたガイダンス文書を発表しました。その結果、外科手術が本格的に再開された後の市場成長を促進すると推定されます。

COVID-19の大流行は、世界中の脊椎外科医の手術や臨床に大きな影響を与えています。アジア太平洋脊椎学会(APSS)の調査によると、COVID-19の大流行は脊椎外科医の臨床実践を変えました。この調査は、パンデミックがアジア太平洋地域の脊椎外科医の臨床診療に与えた影響を調べることを目的としていました。19カ国から合計222名の回答者がアンケートに回答しました。調査の結果、すべての国の診療量の平均減少率は48.1%でした。したがって、マレーシア、日本、インド、フィリピン、韓国では、手術件数の大幅な減少が見られました。

カイフォプラスティは、保存的治療と比較して、より迅速な疼痛緩和と機能的転帰の向上を提供することができます。がんの一つである多発性骨髄腫は背中の骨を弱くし、骨折や後弯を引き起こします。後弯症は、座りっぱなしや悪い姿勢が原因で発症します。座っていると椎骨にかなりの圧力がかかり、椎骨が磨り減ってしまうために発症します。

低侵襲の外科手術に対する需要の増加、医療保険償還の改善、新製品の技術進歩、骨粗鬆症の罹患率の増加などは、予測期間中の市場成長を促進すると予想されるその他の要因です。例えば、2020年9月、StrykerのSpineJack植込み型骨折低減システムは、2021年入院患者前向き支払い制度の一部として米国メディケア&メディケイドサービスセンター(CMS)の新技術加算支払いを受けた。

カイフォプラスティ市場レポートハイライト

  • 骨アクセスデバイスセグメントは、脊椎骨折や腰痛の有病率の上昇により、2022年に市場で最大の収益を生み出す部門となっています。
  • バルーンカテーテルセグメントは有利な成長が見込まれます。次世代バルーンによる技術進歩の増加が、このセグメントの成長を支えています。
  • 用途別では、脊椎骨折セグメントが最大の市場シェアを占め、予測期間中に有利な成長が見込まれます。がんや外傷による脊椎の圧迫骨折の増加が、このセグメントの成長につながっています。
  • 骨粗鬆症セグメントは、2022年の収益で市場全体を支配しました。骨粗鬆症の有病率の増加は、このセグメントを他のセグメントよりも大きな市場シェアに導くと予想されます。
  • 病院セグメントは2022年に最大の市場シェアを占めました。技術的に進歩した医療機器は病院で広く使用されており、市場成長を支えています。
  • 北米は、確立されたメーカーの存在と、同地域で整備された償還構造により、2022年の市場規模を独占しました。
  • 市場は、外科医や患者のニーズの変化により、大手企業が製品イノベーション戦略に注力しているため、競争が激しいです。
  • 2020年5月、メドトロニックは、骨粗鬆症、良性病変、またはがんによって引き起こされる椎骨圧迫骨折の治療のための他のカイフォプラスティ製品を補助するためのKyphon Assist Directional Cannulaを米国で発売しました。 これにより、製品ポートフォリオが拡大します。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • 二次情報のリスト
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

第3章 カイフォプラスティ市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • カイフォプラスティ市場分析ツール
    • 業界分析- ポーター
    • PESTEL分析

第4章 カイフォプラスティ:製品の推定・動向分析

  • カイフォプラスティ市場:重要なポイント
  • カイフォプラスティ市場:動向と市場シェア分析、2022年および2030年
  • バルーンカテーテル
  • 骨アクセスデバイス
  • セメント適用製品
  • 骨セメント
  • セメント混合システム
  • 機器

第5章 カイフォプラスティ:適用の推定・動向分析

  • カイフォプラスティ市場:重要なポイント
  • カイフォプラスティ市場:動向と市場シェア分析、2022年および2030年
  • 脊椎アライメント修復
  • 脊椎骨折
  • 脊柱後湾症

第6章 カイフォプラスティ:適応症の推定・動向分析

  • カイフォプラスティ市場:重要なポイント
  • カイフォプラスティ市場:動向と市場シェア分析、2022年および2030年
  • 骨粗鬆症
  • その他

第7章 カイフォプラスティ:最終使用途の推定・動向分析

  • カイフォプラスティ市場:重要なポイント
  • カイフォプラスティ市場:動向と市場シェア分析、2022年および2030年
  • 病院・クリニック
  • 外来手術センター(ASC)

第8章 カイフォプラスティ市場:地域の推定・動向分析

  • 地域別の展望
  • 地域別のカイフォプラスティ市場:主要マーケットプレースの要点
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • STRYKER
    • MEDTRONIC
    • SMITH + NEPHEW
    • MICROPORT SCIENTIFIC CORPORATION
    • DEPUY SYNTHES (JOHNSON & JOHNSON SERVICES INC.)
    • IZI Medical Products
    • CAREFUSION (A BD COMPANY)
    • MERIT MEDICAL SYSTEMS
    • JOIMAX GMBH
    • G21 S.R.L.
    • JOLINE GMBH & CO.KG
    • SEAWON MEDITECH
    • HENSLER SURGICAL PRODUCTS
    • TAEYEON MEDICAL
    • IMEDICOM
    • JIANGSU CHANGMEI MEDTECH CO., LTD
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 5 North America kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America kyphoplasty market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 10 U.S. kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 14 Canada kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Europe kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 22 Germany kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 UK kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 26 UK kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 France kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 28 France kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 29 France kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 30 France kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Italy kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 32 Italy kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Italy kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 38 Spain kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 40 Sweden kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 41 Sweden kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 42 Sweden kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Norway kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 44 Norway kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 45 Norway kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Norway kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Denmark kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 48 Denmark kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Denmark kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 China kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 56 China kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 57 China kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 58 China kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Japan kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 60 Japan kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 61 Japan kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Japan kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 India kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 64 India kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 65 India kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 66 India kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Thailand kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 68 Thailand kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 69 Thailand kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Thailand kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 South Korea kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 72 South Korea kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 73 South Korea kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 74 South Korea kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Latin America kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 76 Latin America kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 77 Latin America kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Latin America kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Brazil kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 80 Brazil kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 81 Brazil kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Brazil kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Mexico kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 84 Mexico kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 85 Mexico kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 86 Mexico kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Argentina kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 88 Argentina kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 89 Argentina kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 90 Argentina kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Middle East and Africa kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 92 Middle East and Africa kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 93 Middle East and Africa kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 94 Middle East and Africa kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 South Africa kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 96 South Africa kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 97 South Africa kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 98 South Africa kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Saudi Arabia kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 100 Saudi Arabia kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 101 Saudi Arabia kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 102 Saudi Arabia kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 UAE kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 104 UAE kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 105 UAE kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 106 UAE kyphoplasty market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Kuwait kyphoplasty market, by product, 2018 - 2030 (USD Million)
  • Table 108 Kuwait kyphoplasty market, by application, 2018 - 2030 (USD Million)
  • Table 109 Kuwait kyphoplasty market, by indication, 2018 - 2030 (USD Million)
  • Table 110 Kuwait kyphoplasty market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Kyphoplasty: market outlook
  • Fig. 9 Kyphoplasty competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Kyphoplasty market driver impact
  • Fig. 15 Kyphoplasty market restraint impact
  • Fig. 16 Kyphoplasty market strategic initiatives analysis
  • Fig. 17 Kyphoplasty market: Product movement analysis
  • Fig. 18 Kyphoplasty market: Product outlook and key takeaways
  • Fig. 19 Balloon catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Bone access devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Cement application products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Bone cement market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Cement mixing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Kyphoplasty market: Application movement analysis
  • Fig. 26 Kyphoplasty market: Application outlook and key takeaways
  • Fig. 27 Vertebral alignment restoration market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Spinal fractures market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Kyphosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Kyphoplasty market: Indication movement analysis
  • Fig. 31 Kyphoplasty market: Indication outlook and key takeaways
  • Fig. 32 Osteoporosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Kyphoplasty market: End-use movement analysis
  • Fig. 35 Kyphoplasty market: End-use outlook and key takeaways
  • Fig. 36 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Global kyphoplasty market: regional movement analysis
  • Fig. 39 Global kyphoplasty market: regional outlook and key takeaways
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-942-4

Kyphoplasty Market Growth & Trends

The global kyphoplasty market size is expected to reach USD 950.8 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.3% from 2023 to 2030. The increasing geriatric population is a key contributing factor attributable to the market growth during the forecast period. Compression fractures affect many individuals worldwide. Vertebral compression fractures (VCFs) are the most common fracture in osteoporosis patients, affecting approximately 750,000 people every year. The occurrence of this condition gradually rises as people age, with an estimated 40% of women aged 80 and older affected.

During the outbreak of COVID-19, non-emergency procedures have significantly impacted the Kyphoplasty market. As restrictions resulted in delays to a number of procedures. Most nations have elevated restrictions on elective surgery. In April 2020, the North American Spine Society (NASS) released a guidance document comprehensive of clinical considerations and recommendations for surgeries and procedures within the following classes: emergent, urgent, and elective. As a result, it is estimated to drive market growth after the recommencement of surgical procedures at full force.

The COVID-19 pandemic has significantly affected the surgical and clinical practice of spine surgeons across the globe. As per an Asia Pacific Spine Society (APSS) Survey, the COVID-19 pandemic had changed spine surgeons' clinical practices. The study intended to examine the impact of the pandemic on the clinical practices of spine surgeons within the Asia Pacific region. A total of 222 respondents from 19 nations completed the questionnaire. The study resulted in the mean reduction of clinic volume for all nations was 48.1%. Thus, there was a substantial decrease in the number of surgeries performed in Malaysia, Japan, India, the Philippines, and South Korea.

Kyphoplasty can offer faster pain relief and enhanced functional outcomes compared with conservative treatment. Multiple myeloma, one of the cancer form weaken the bones of the back, which leads to fractures and kyphosis. While continuous sitting and bad posture can be the reason for the development of kyphosis. It develops because sitting puts substantial pressure on the vertebrae, wearing them down.

Increasing demand for minimally invasive surgical procedures, improving health reimbursement, technological advancement in new products, and increasing incidence of osteoporosis are other factors expected to promote the market growth during the forecast period. For instance, in September 2020, Stryker's SpineJack implantable fracture reduction system received the U.S. Centers for Medicare & Medicaid Services (CMS) new technology add-on payment as part of the 2021 inpatient prospective payment system.

Kyphoplasty Market Report Highlights

  • Bone access devices segment was the largest revenue-generating segment of the market in 2022 owing to the rising prevalence of spine fractures, back pain
  • Balloon catheters segment is anticipated to witness lucrative growth. The increasing number of technological advancements with the beginning of next-generation kyphoplasty balloons supports segment growth
  • On the basis of application, the spinal fractures segment held the largest market share and witnessed lucrative growth over the forecast period. Rising incidences of compressed bones of the spine due to cancer, and trauma has led to the growth of the segment
  • Osteoporosis segment dominated the overall market in terms of revenue in 2022. The increasing prevalence of osteoporosis is expected to lead the segment to its large market share over the other segment
  • Hospitals segment held the largest market share in 2022. Technologically-advanced medical devices are being used extensively in hospitals, thus supports in market growth
  • North America dominated in 2022 due to the presence of established manufacturers and a well-developed reimbursement structure in the region
  • The market is highly competitive in nature as major players are focusing on the product innovation strategies due to changing needs of surgeons and patients
  • In May 2020, Medtronic launched its Kyphon Assist Directional Cannula in the U.S. for assisting its other kyphoplasty products for the treatment of vertebral compression fractures caused due to osteoporosis, benign lesions, or cancer. Thereby, expanding its product portfolio

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Indication
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Indication
    • 2.2.4. End-Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Kyphoplasty Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
    • 3.4.2. Market restraint analysis
  • 3.5. Kyphoplasty Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. The threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Kyphoplasty: Product Estimates & Trend Analysis

  • 4.1. Kyphoplasty Market: Key Takeaways
  • 4.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Balloon Catheters
    • 4.3.1. Balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Bone Access Devices
    • 4.4.1. Bone access devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Cement Application Products
    • 4.5.1. Cement application products market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Bone Cement
    • 4.6.1. Bone cements market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Cement Mixing System
    • 4.7.1. Cement mixing system market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Instruments
    • 4.8.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Kyphoplasty: Application Estimates & Trend Analysis

  • 5.1. Kyphoplasty Market: Key Takeaways
  • 5.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Vertebral Alignment Restoration
    • 5.3.1. Vertebral alignment restoration market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Spinal Fractures
    • 5.4.1. Spinal fractures market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Kyphosis
    • 5.5.1. Kyphosis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Kyphoplasty: Indication Estimates & Trend Analysis

  • 6.1. Kyphoplasty Market: Key Takeaways
  • 6.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Osteoporosis
    • 6.3.1. Osteoporosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Kyphoplasty: End-use Estimates & Trend Analysis

  • 7.1. Kyphoplasty Market: Key Takeaways
  • 7.2. Kyphoplasty Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals and clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Ambulatory Surgical Centers (ASCs)
    • 7.4.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Kyphoplasty Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Kyphoplasty Market by Region: Key Marketplace Takeaway
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. The U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Market Participant Categorization
    • 9.2.1. STRYKER
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. MEDTRONIC
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. SMITH + NEPHEW
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. MICROPORT SCIENTIFIC CORPORATION
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. DEPUY SYNTHES (JOHNSON & JOHNSON SERVICES INC.)
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. IZI Medical Products
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. CAREFUSION (A BD COMPANY)
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. MERIT MEDICAL SYSTEMS
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. JOIMAX GMBH
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. G21 S.R.L.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. JOLINE GMBH & CO.KG
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. SEAWON MEDITECH
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. HENSLER SURGICAL PRODUCTS
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. TAEYEON MEDICAL
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Product benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. IMEDICOM
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Product benchmarking
      • 9.2.15.4. Strategic initiatives
    • 9.2.16. JIANGSU CHANGMEI MEDTECH CO., LTD
      • 9.2.16.1. Company overview
      • 9.2.16.2. Financial performance
      • 9.2.16.3. Product benchmarking
      • 9.2.16.4. Strategic initiatives